Swiss National Bank
PRAX icon

Swiss National Bank’s Praxis Precision Medicines PRAX Stock Holding History

Swiss National Bank’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15M Buy
46,700
+6,200
+15% +$1.92M 0.01% 759
2025
Q4 		$11.9M Buy
40,500
+5,000
+14% +$931K 0.01% 872
2025
Q3 		$1.88M Buy
35,500
+4,700
+15% +$228K ﹤0.01% 1883
2025
Q2 		$1.3M Buy
30,800
+3,700
+14% +$141K ﹤0.01% 2019
2025
Q1 		$1.03M Buy
27,100
+1,000
+4% +$62.5K ﹤0.01% 2120
2024
Q4 		$2.01M Buy
26,100
+1,000
+4% +$72.4K ﹤0.01% 1850
2024
Q3 		$1.44M Sell
25,100
-6,900
-22% -$373K ﹤0.01% 2037
2024
Q2 		$1.32M Buy
+32,000
New +$1.51M ﹤0.01% 2030
2022
Q4 		– Sell
-5,720
Closed -$195K – 2713
2022
Q3 		$195K Hold
5,720
– – ﹤0.01% 2695
2022
Q2 		$210K Buy
5,720
+2,180
+62% +$233K ﹤0.01% 2730
2022
Q1 		$542K Buy
3,540
+260
+8% +$53.4K ﹤0.01% 2585
2021
Q4 		$969K Buy
3,280
+80
+3% +$23.5K ﹤0.01% 2491
2021
Q3 		$888K Hold
3,200
– – ﹤0.01% 2470
2021
Q2 		$877K Buy
+3,200
New +$1.15M ﹤0.01% 2526

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Swiss National Bank's PRAX Position: Q1 2026 in Review

Swiss National Bank increased its Praxis Precision Medicines (PRAX) stake by 15% in Q1 2026, buying an estimated $1.92M and bringing the position to 46,700 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #759.

Swiss National Bank first reported a position in PRAX in Q2 2021 and has held it in 14 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Swiss National Bank held 46,700 shares of Praxis Precision Medicines worth $15M as of Q1 2026.
  • Swiss National Bank bought 6,200 Praxis Precision Medicines shares in Q1 2026, an estimated $1.92M.
  • Praxis Precision Medicines made up 0.01% of Swiss National Bank's portfolio in Q1 2026, its #759 holding.
  • Swiss National Bank first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 14 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.